Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document
Por:
Bozkurt, B, Mullens, W, Leclercq, C, Russo, AM, Savarese, G, Böhm, M, Hill, L, Kinugawa, K, Sato, N, Abraham, WT, Bayes-Genis, A, Mebazaa, A, Rosano, GMC, Zieroth, S, Linde, C and Butler, J
Publicada:
1 jul 2025
Ahead of Print:
1 abr 2025
Resumen:
Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision-making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices are frequently referred too late or not at all. Misconceptions about device therapy and the notion that the needs of patients (especially the prevention of sudden cardiac death) can now be met by expanding drug therapies may play a role in these disparities. This state-of-the-art review is produced by members of the DIRECT HF initiative, a patient-centred, expert-led educational programme that aims to advance guideline-directed use of CRM devices in patients with HFrEF. This review discusses the latest evidence on the role of CRM devices in reducing HFrEF mortality and morbidity, and provides practical guidance on patient referral, device selection, implant timing and patient-centred follow-up.
Filiaciones:
Bozkurt, B:
Baylor Coll Med, Houston, TX USA
Mullens, W:
Ziekenhuis Oost Limburg, Genk, Belgium
Hasselt Univ, Hasselt, Belgium
Leclercq, C:
Univ Rennes, Rennes, France
Russo, AM:
Rowan Univ, Cooper Med Sch, Camden, NJ USA
Savarese, G:
Karolinska Inst, Stockholm, Sweden
Böhm, M:
Saarland Univ, Homburg, Germany
Hill, L:
Queens Univ Belfast, Belfast, North Ireland
Kinugawa, K:
Univ Toyama, Toyama, Japan
Sato, N:
Kawaguchi Cardiovasc & Resp Hosp, Saitama, Japan
Abraham, WT:
Ohio State Univ, Sch Med, Columbus, OH USA
:
Autonomous Univ Barcelona, CIBERCV, Barcelona, Spain
Mebazaa, A:
Univ Paris Cite, MASCOT, APHP, Inserm Unit, Paris, France
Rosano, GMC:
San Raffaele Open Univ Rome, Dept Human Sci & Promot Qual Life, Rome, Italy
San Raffaele Cassino Hosp, Cardiol, Cassino, Italy
IRCCS San Raffaele Roma, Rome, Italy
City St Georges Univ London, Mol & Clin Sci Res Inst, Cardiol Clin Acad Grp, London, England
Zieroth, S:
Univ Manitoba, Max Rady Coll Med, Winnipeg, MB, Canada
Linde, C:
Karolinska Inst, Stockholm, Sweden
Butler, J:
Baylor Scott & White Res Inst, Dallas, TX USA
Univ Mississippi, Jackson, MS USA
Green Submitted
|